Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Orchid Pharma's Pre-Tax Income for the
three
months ended in Mar. 2026 was $2.46 Mil. Orchid Pharma's Revenue for the
three
months ended in Mar. 2026 was $25.60 Mil. Therefore, Orchid Pharma's pretax margin for the quarter that ended in Mar. 2026 was 9.59%.
The historical rank and industry rank for Orchid Pharma's Pretax Margin % or its related term are showing as below:
LUX:ORCHP'
s Pretax Margin % Range Over the Past 10 Years
Min: -68.27 Med: -3.79 Max: 11.57
Current: 2.59
LUX:ORCHP's Pretax Margin % is ranked worse than 61.76% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs LUX:ORCHP: 2.59
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Orchid Pharma Pretax Margin % Related Terms
Orchid Pharma Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Orchid Pharma's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LUX:ORCHP vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Orchid Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orchid Pharma Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orchid Pharma's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Orchid Pharma's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orchid Pharma (LUX:ORCHP) has a Pretax Margin % of 9.59% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Orchid Pharma and its competitors. According to the industry distribution chart, Orchid Pharma ranks #588 out of 952 companies in the Drug Manufacturers industry, placing it in the top 61.8%.
Is Orchid Pharma's Pretax Margin % too high?
Orchid Pharma's current Pretax Margin % is 9.59%. The Drug Manufacturers industry median Pretax Margin % is 7.30. Orchid Pharma's value of 9.59% is 31.5% above this industry median. Based on the distribution chart, Orchid Pharma ranks #588 out of 952 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Orchid Pharma has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Orchid Pharma's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Orchid Pharma ranks #588 out of 952 companies for Pretax Margin %. This places Orchid Pharma in the lower half of its industry. The industry median Pretax Margin % is 7.30. Orchid Pharma's value of 9.59% is 31.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orchid Pharma's current Pretax Margin % of 9.59% is 31.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Orchid Pharma and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orchid Pharma's current Pretax Margin % is 9.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orchid Pharma stock overvalued right now?
Orchid Pharma (LUX:ORCHP) has a current Pretax Margin % of 9.59%. The stock's GF Value™ is $4.60, compared to a current price of $5.45 — trading 18.5% above its estimated fair value. The current Pretax Margin % is 9.59% and 31.5% above the Drug Manufacturers industry median of 7.30. Orchid Pharma's overall GF Score™ is 60/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Orchid Pharma (LUX:ORCHP), the current Pretax Margin % is 9.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orchid Pharma (LUX:ORCHP) Overvalued in 2026?
Based on GuruFocus' analysis, Orchid Pharma stock appears to be overvalued.
The current stock price of $5.45 is trading 18.5% above its estimated GF Value™ of $4.60.
Key valuation signals for LUX:ORCHP:
Pretax Margin %: 9.59%
GF Value™: $4.60 vs. price of $5.45 (18.5% above fair value)
Industry Position: 31.5% above the Drug Manufacturers median (#588 of 952)
No single metric tells the full story. See the LUX:ORCHP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment, which is Pharmaceuticals, in which the company derives its maximum sales through Active Pharmaceutical Ingredients. It produces various products such as tablets, injectables, and APIs for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotic, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. Geographically, the company generates maximum revenue from the export of its products to international markets like the United States, Canada, Europe, Japan, Australia, and China etc., and the rest from its business in India.
60GF Score
Get the complete analysis for LUX:ORCHP
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUX:ORCHP has been successfully added to your 
